Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingkepingchuan Granules for Acute Exacerbation of COPD
NCT06143358Completed
- Start
- Jan 2022
- Primary completion
- Jul 2023
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Trial of qingkepingchuan in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoints: Chinese Medicine Symptoms Scale, COPD Assessment Test and 1 more. Started Jan 2022; status: completed.
02
Drugs
qingkepingchuan
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06143358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06143358.